Objective:Currently,only a limited numbers of tumor markers for non small lung cancer(NSCLC) diagnosis,new biomarker,such as serum autoantibodies may improve the early detection of lung cancer.Our objective is constru...Objective:Currently,only a limited numbers of tumor markers for non small lung cancer(NSCLC) diagnosis,new biomarker,such as serum autoantibodies may improve the early detection of lung cancer.Our objective is construction human lung squamous carcinoma and adenocarcinoma T7 phage display cDNA library from the tissues of NSCLC patients.Methods:mRNA was isolated from a pool of total RNA extract from NSCLC tissues obtained from 5 adenocarcinomas and 5 squamous carcinomas,and then mRNA was reverse transcribed into double stranded cDNA.After digestion,the cDNA was inserted into T7Select 10-3 vector.The phage display cDNA library was constructed by package reaction in vitro and plate proliferation.Plaque assay and PCR were used to evaluate the library.Results:Two T7 phage display cDNA library were established.Plaque assay show the titer of lung squamas carcinoma library was 1.8 × 106 pfu,and the adenocarcinoma library was 5 × 106 pfu.The phage titer of the amplified library were 3.2 × 1010 pfu/mL and 2.5 × 1010 pfu/mL.PCR amplifica-tion of random plaque show insert ratio were 100%(24/24) in adenocarcinoma library and 95.8% in human lung squamas carcinoma library(23/24).Insert range from 300 bp to 1 500 bp.Conclusion:Two phage display cDNA library from NSCLC were constructed.展开更多
Objective: The aim of this study was to use lung cancer targeting binding polypeptide ZS-9 to screen cDNA library of human lung cancer and obtain ZS-9 specific ligand to confirm tumor marker of non small-cell lung can...Objective: The aim of this study was to use lung cancer targeting binding polypeptide ZS-9 to screen cDNA library of human lung cancer and obtain ZS-9 specific ligand to confirm tumor marker of non small-cell lung cancer. Methods: Artificially synthesize biotin labeled peptide ZS-9, anchored ZS-9 in the enzyme label plate coupled by avidin, used ZS-9 as probe to screen cDNA library of human lung cancer, after screening, obtained bacteriophage clone specifically binding with anchored polypeptide ZS-9. Extracted plasmid of bacteriophage and performed sequencing after amplified by PCR. Results: It was demonstrated by bioinformatic analysis on the sequence of ligand binded by lung cancer specific peptide ZS-9 that the ligand was the cytoskeletal protein periplakin on the surface of lung cancer cells, suggesting that periplakin might be a new marker for non-small-cell lung cancer in lung cancer. Conclusion: Use specific lung cancer binding peptide to screen new tumor marker periplakin in lung cancer and further studies on its biologic functions in genesis and development of lung cancer are still needed.展开更多
基金Supported by the grants of Beijing Novel Program (No.2006B34)Scientific Research Foundation for the Returned Overseas Chinese Scholars,State Education Ministry and Beijing Research Foundation for Excellent Talents (No.20061D03)
文摘Objective:Currently,only a limited numbers of tumor markers for non small lung cancer(NSCLC) diagnosis,new biomarker,such as serum autoantibodies may improve the early detection of lung cancer.Our objective is construction human lung squamous carcinoma and adenocarcinoma T7 phage display cDNA library from the tissues of NSCLC patients.Methods:mRNA was isolated from a pool of total RNA extract from NSCLC tissues obtained from 5 adenocarcinomas and 5 squamous carcinomas,and then mRNA was reverse transcribed into double stranded cDNA.After digestion,the cDNA was inserted into T7Select 10-3 vector.The phage display cDNA library was constructed by package reaction in vitro and plate proliferation.Plaque assay and PCR were used to evaluate the library.Results:Two T7 phage display cDNA library were established.Plaque assay show the titer of lung squamas carcinoma library was 1.8 × 106 pfu,and the adenocarcinoma library was 5 × 106 pfu.The phage titer of the amplified library were 3.2 × 1010 pfu/mL and 2.5 × 1010 pfu/mL.PCR amplifica-tion of random plaque show insert ratio were 100%(24/24) in adenocarcinoma library and 95.8% in human lung squamas carcinoma library(23/24).Insert range from 300 bp to 1 500 bp.Conclusion:Two phage display cDNA library from NSCLC were constructed.
基金Supported by grants from the Science and Technology Planning Project of Guangdong Province (No. 2010B031600066 No. 2010B031500034+2 种基金 No. 2008B030303008)the Key Scientific Subject Foundation of Ministry of Education of China (No. 208105)the National Science and Technology Major Projects for New Drugs (No. 2011zx09102-001-31)
文摘Objective: The aim of this study was to use lung cancer targeting binding polypeptide ZS-9 to screen cDNA library of human lung cancer and obtain ZS-9 specific ligand to confirm tumor marker of non small-cell lung cancer. Methods: Artificially synthesize biotin labeled peptide ZS-9, anchored ZS-9 in the enzyme label plate coupled by avidin, used ZS-9 as probe to screen cDNA library of human lung cancer, after screening, obtained bacteriophage clone specifically binding with anchored polypeptide ZS-9. Extracted plasmid of bacteriophage and performed sequencing after amplified by PCR. Results: It was demonstrated by bioinformatic analysis on the sequence of ligand binded by lung cancer specific peptide ZS-9 that the ligand was the cytoskeletal protein periplakin on the surface of lung cancer cells, suggesting that periplakin might be a new marker for non-small-cell lung cancer in lung cancer. Conclusion: Use specific lung cancer binding peptide to screen new tumor marker periplakin in lung cancer and further studies on its biologic functions in genesis and development of lung cancer are still needed.